IR

IR

Financial results

FY 2024

1st Quarter

Summary of Financial Results

Summary of Non-Consolidated Financial Results for the Three Months Ended December 31, 2023 (Based on Japanese GAAP)

Financial Results Briefings and Supplemental Materials

Supplemental Material for the Three Months Ended December 31, 2023

2nd Quarter

Summary of Financial Results

Summary of Non-Consolidated Financial Results for the Six Months Ended March 31, 2024(Based on Japanese GAAP)

Financial Results Briefings and Supplemental Materials

Presentation Slides on Non-Consolidated Financial Results for the Six Months Ended March 31, 2024

3rd Quarter

Summary of Financial Results

Summary of Non-Consolidated Financial Results for the Six Months Ended March 31, 2024(Based on Japanese GAAP)

Financial Results Briefings and Supplemental Materials

Supplemental Material for the Nine Months Ended June 30, 2024

4th Quarter

Summary of Financial Results

Summary of Non-Consolidated Financial Results for the Year Ended September 30, 2024 (Based on Japanese GAAP)

Financial Results Briefings and Supplemental Materials

Presentation Slides on Non-Consolidated Financial Results for the Year Ended September 30, 2024

IR News

View all IR news

Notice of Resolutions at the 33rd Annual General Meeting of Shareholders

Status of Progress in Plan to Meet the Criteria for Maintaining Listing

Notice of Convocation Annual General Meeting 2024

Notice of the Launch of the English Corporate Website

Presentation Slides on Non-Consolidated Financial Results for the Year Ended September 30, 2024

Top Message

Top Message

About CDC

About CDC

IR Library

IR Library

Financial Highlight

Financial Highlight

Medium-Term Management Plan

Medium-Term Management Plan

IR Calendar

General Meeting of Shareholders

General Meeting of Shareholders

Stock Information

Stock Information

Disclosure Policy

Disclosure Policy

シェアードリサーチ社による当社の調査レポートはこちら SharedResearch